DK2344892T3 - Glucuronideret paracetamol som markør for hepatiske lidelser - Google Patents

Glucuronideret paracetamol som markør for hepatiske lidelser

Info

Publication number
DK2344892T3
DK2344892T3 DK09740779.5T DK09740779T DK2344892T3 DK 2344892 T3 DK2344892 T3 DK 2344892T3 DK 09740779 T DK09740779 T DK 09740779T DK 2344892 T3 DK2344892 T3 DK 2344892T3
Authority
DK
Denmark
Prior art keywords
glucuronidated
paracetamol
marker
hepatic disorders
hepatic
Prior art date
Application number
DK09740779.5T
Other languages
English (en)
Inventor
Nathan Cherrington
Original Assignee
Univ Arizona State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State filed Critical Univ Arizona State
Application granted granted Critical
Publication of DK2344892T3 publication Critical patent/DK2344892T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK09740779.5T 2008-10-01 2009-09-30 Glucuronideret paracetamol som markør for hepatiske lidelser DK2344892T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19483508P 2008-10-01 2008-10-01
PCT/US2009/058913 WO2010039754A1 (en) 2008-10-01 2009-09-30 Glucuronidated acetaminophen as a marker of hepatic disorders

Publications (1)

Publication Number Publication Date
DK2344892T3 true DK2344892T3 (da) 2014-08-18

Family

ID=41478549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09740779.5T DK2344892T3 (da) 2008-10-01 2009-09-30 Glucuronideret paracetamol som markør for hepatiske lidelser

Country Status (21)

Country Link
US (2) US20110220500A1 (da)
EP (1) EP2344892B8 (da)
JP (2) JP2012504629A (da)
KR (1) KR20110082148A (da)
CN (1) CN102227641B (da)
AU (1) AU2009298669B2 (da)
BR (1) BRPI0920441A2 (da)
CA (1) CA2738210A1 (da)
CL (1) CL2011000654A1 (da)
DK (1) DK2344892T3 (da)
ES (1) ES2489016T3 (da)
HK (1) HK1160223A1 (da)
IL (1) IL211914A (da)
MX (1) MX2011003497A (da)
MY (1) MY156251A (da)
NZ (1) NZ591981A (da)
PL (1) PL2344892T3 (da)
PT (1) PT2344892E (da)
RU (1) RU2555331C2 (da)
WO (1) WO2010039754A1 (da)
ZA (1) ZA201102369B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4390397A1 (en) * 2022-12-23 2024-06-26 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Methods for diagnosing liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090845B2 (en) * 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
US7470513B2 (en) * 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions

Also Published As

Publication number Publication date
EP2344892B1 (en) 2014-05-21
KR20110082148A (ko) 2011-07-18
PT2344892E (pt) 2014-08-25
AU2009298669A1 (en) 2010-04-08
HK1160223A1 (en) 2012-08-10
IL211914A0 (en) 2011-06-30
CA2738210A1 (en) 2010-04-08
AU2009298669B2 (en) 2016-04-07
RU2011117260A (ru) 2012-11-10
NZ591981A (en) 2013-05-31
JP2015155913A (ja) 2015-08-27
ES2489016T3 (es) 2014-09-01
WO2010039754A1 (en) 2010-04-08
IL211914A (en) 2015-09-24
US20110220500A1 (en) 2011-09-15
CN102227641B (zh) 2015-04-22
BRPI0920441A2 (pt) 2017-05-30
MX2011003497A (es) 2011-07-29
US20160209435A1 (en) 2016-07-21
RU2555331C2 (ru) 2015-07-10
EP2344892A1 (en) 2011-07-20
ZA201102369B (en) 2012-09-26
JP2012504629A (ja) 2012-02-23
PL2344892T3 (pl) 2014-10-31
CL2011000654A1 (es) 2011-08-19
MY156251A (en) 2016-01-29
CN102227641A (zh) 2011-10-26
EP2344892B8 (en) 2014-11-12

Similar Documents

Publication Publication Date Title
BRPI0918971A2 (pt) tienopirimidinas para composições farmacêuticas
BRPI0817909A2 (pt) Intermediários e métodos para a síntese de análogos de halicondrina
DK2326651T3 (da) Buprenorphinanaloger
DK2114143T3 (da) Flydende sulfonylurea-herbicidformuleringer
BRPI0810139A2 (pt) Catalisador para a preparação de metil mercaptano
IT1394132B1 (it) Trivella semovente per carotaggi
BRPI0814063A2 (pt) Cabeça dispensadora
DK2271618T3 (da) Farmaceutiske forbindelser
BRPI0821837A2 (pt) Processo para a preparação de 6-substituídas-1-(2h)-isoquinolinonas
BRPI0908497A2 (pt) métodos e composições para um rendimento aumentado
BRPI0914531A2 (pt) "método para a preparação de um polimorfo a"
DK2344892T3 (da) Glucuronideret paracetamol som markør for hepatiske lidelser
BRPI0912740A2 (pt) processos para a preparação de amidas
BRPI0918190A2 (pt) metodo para administrar agentes farmaceuticos
ES1065835Y (es) Caperuza para cetreria
ES1067107Y (es) Entresuela para calzado
BRPI0818455A2 (pt) Processo para a preparação de 7-alil-6-hidróxi-indanos substituídos
ES1063735Y (es) Testero para persiana
ES1065747Y (es) Pieza de union central para mosquiteras
ES1067042Y (es) Horca para la construccion
UA15577S (uk) Етикетка для вафель
ES1066482Y (es) Pieza constructiva para paramento
FI20080013A0 (fi) Uudet farmaseuttiset formulaatiot
ITRM20070237U1 (it) Distributore meccanico per chewingum
UA15147S (uk) Етикетка для печива